title: First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCG.
abstract: To compare free beta hCG versus intact hCG in first trimester Down syndrome screening we analysed 63 cases of Down syndrome and 400 unaffected control pregnancies between 10 and 13 weeks' gestation. The Down syndrome median multiple of the median (MoM) was significantly higher (p=0.001) for free beta hCG (1.89 MoM) than for intact hCG (1.37 MoM). Although distributions for free beta hCG (unaffected, 0.2157; DS, 0.2322) are wider than for intact hCG (unaffected, 0.1697; DS, 0.2158), overall 27% of Down syndrome cases were above the 95th percentile for free beta hCG compared to 19% for intact hCG. Combined with maternal age, free beta hCG detected 45% of Down syndrome pregnancies at a 5% false positive rate. Intact hCG combined with maternal age demonstrated a detection efficiency comparable to maternal age alone (35% versus 32%). In contrast, a recent study (Haddow et al., 1998-NEJM 338: 955-961) indicated that intact hCG yielded a higher first trimester Down syndrome detection efficiency than free beta hCG (29% versus 25% respectively). Re-analysis of distribution parameters in the Haddow et al. study, however, show that free beta hCG was actually the better marker (23% detection for intact hCG versus 29% for free beta hCG).
authors.affiliation: NTD Laboratories, Inc., Huntington Station, NY 11746, USA. NTDLabs@aol.com
authors.forename: T
authors.initials: T
authors.lastname: Hallahan
authors.forename: D
authors.initials: D
authors.lastname: Krantz
authors.forename: F
authors.initials: F
authors.lastname: Orlandi
authors.forename: C
authors.initials: C
authors.lastname: Rossi
authors.forename: P
authors.initials: P
authors.lastname: Curcio
authors.forename: S
authors.initials: S
authors.lastname: Macri
authors.forename: J
authors.initials: J
authors.lastname: Larsen
authors.forename: P
authors.initials: P
authors.lastname: Buchanan
authors.forename: J
authors.initials: J
authors.lastname: Macri
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D006063:Chorionic Gonadotropin / Q000097:blood; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood*; D004314:Down Syndrome / Q000097:blood / Q000175:diagnosis*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods* / Q000592:standards; D011237:Predictive Value of Tests; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011296:Prenatal Diagnosis
chemical_list: D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human